December 8, 2012

Don’t Be Surprised If Underpriced Small-Cap Biotechs Catch Investors’ Eye Once Again

Written By Gene Marcial, Contributor

Biotechnology stocks haven’t produced much excitement for investors this year, partly because the Presidential elections and national politics usurped much of the news headlines. So Wall Street and most investors have had little chance or inclination to focus on this beguiling if complicated sector.

Even so, they haven’t performed badly in recent weeks, with the biotech BTK Index up 6.6%, although they still trailed the S&P 500’s 8.4% rise and the Nasdaq’s 12% jump.

The biotechs should, however, get renewed attention as various important biotech industry groups that attract thousands of healthcare investors and professionals start holding their annual conventions and meetings where biotech and life science companies offer their outlook for the coming new year and present updates on their new products and technologies.  …read more